Related Experiment Video
Updated: Aug 29, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells
K Vanoverberghe1, F Vanden Abeele, P Mariot
1Laboratoire de Physiologie Cellulaire, INSERM EMI 0228, Université des Sciences et Technologies de Lille, Bât. SN3, Villeneuve d'Ascq 59655, France.
Abstract:
Neuroendocrine (NE) differentiation is a hallmark of advanced, androgen-independent prostate cancer, for which there is no successful therapy. NE tumor cells are nonproliferating and escape apoptotic cell death; therefore, an understanding of the apoptotic status of the NE phenotype is imperative for the development of new therapies for prostate cancer. Here, we report for the first time on alterations in intracellular Ca(2+) homeostasis, which is a key factor in apoptosis, caused by NE differentiation of androgen-dependent prostate cancer epithelial cells. NE-differentiating regimens, either cAMP elevation or androgen deprivation, resulted in a reduced endoplasmic reticulum Ca(2+)-store content due to both SERCA 2b Ca(2+) ATPase and luminal Ca(2+) binding/storage chaperone calreticulin underexpression, and to a downregulated store-operated Ca(2+) current. NE-differentiated cells showed enhanced resistance to thapsigargin- and TNF-alpha-induced apoptosis, unrelated to antiapoptotic Bcl-2 protein overexpression. Our results suggest that targeting the key players determining Ca(2+) homeostasis in an attempt to enhance the proapoptotic potential of malignant cells may prove to be a useful strategy in the treatment of advanced prostate cancer.
Insights
Neuroendocrine differentiation in prostate cancer alters intracellular calcium (Ca2+) handling, leading to reduced endoplasmic reticulum Ca2+ stores. This impacts apoptosis, offering potential therapeutic targets for advanced prostate cancer treatment.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Neuroendocrine (NE) differentiation is characteristic of advanced, therapy-resistant prostate cancer.
- NE tumor cells exhibit resistance to apoptosis, necessitating research into their cell death mechanisms.
- Intracellular calcium (Ca2+) homeostasis is a critical regulator of apoptosis.
Purpose of the Study:
- To investigate the impact of NE differentiation on intracellular Ca2+ homeostasis in prostate cancer cells.
- To elucidate the role of Ca2+ dysregulation in the apoptotic resistance of NE prostate cancer.
Main Methods:
- Induction of NE differentiation in androgen-dependent prostate cancer cells using cAMP elevation or androgen deprivation.
- Assessment of intracellular Ca2+ levels, endoplasmic reticulum Ca2+ stores, and store-operated Ca2+ currents.
- Evaluation of apoptosis induction using thapsigargin and TNF-alpha.
Main Results:
- NE differentiation led to reduced endoplasmic reticulum Ca2+ stores due to decreased SERCA 2b Ca2+ ATPase and calreticulin expression.
- Store-operated Ca2+ currents were downregulated in NE-differentiated cells.
- NE-differentiated cells demonstrated enhanced resistance to apoptosis, independent of Bcl-2 overexpression.
Conclusions:
- NE differentiation significantly alters Ca2+ homeostasis in prostate cancer cells.
- Targeting key regulators of Ca2+ homeostasis may enhance apoptosis and provide a therapeutic strategy for advanced prostate cancer.
More Related Videos
06:44Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Treatment Resistant Cancers
Caspases
Cellular Injury V: Apoptosis and Autophagy
Autocrine Signaling
Abnormal Proliferation